Fusion Antibodies plc announces that Stephen Smyth has been appointed as interim Chief Financial Officer of the Company with immediate effect. Stephen has over 25 years' experience working in audit & accounting, finance, and operations management within both the public accounting and commercial sectors. Stephen's previous roles include acting as Chief Financial Officer at Sera Global LP, as well as holding senior finance functions at Cormark Securities Inc. and at PricewaterhouseCoopers (PwC) LLP.

Stephen is a chartered accountant and is currently a partner at FPM, a Chartered Accountancy practice with offices throughout the Republic of Ireland and Northern Ireland, including Belfast. At FPM, he provides virtual finance function solutions to clients ranging from start-ups to private equity backed multinationals. As part of the ongoing efforts to preserve cash, Fusion will be utilising the services of Stephen on a part-time basis, supported by a team at FPM, who will provide the Company with outsourced finance function services.

It is anticipated that the Company will utilise the services of Stephen and FPM until such time that the trading recovers to levels that would support the appointment of a permanent CFO and in-house finance function.